Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Imaging Dynamics CoIDYLF +152.69%9 3-Year EBITDA Growth Rate is 8.30% as of Mar. 2026, which is 67% below its 10-year median of 25.50. GuruFocus rates IDYLF with a GF Score™ of 9/100 and a GF Value™ of $0.01. The stock has 7 warning signs investors should review. Among 688 Medical Devices & Instruments companies, Imaging Dynamics Co ranks better than 50.29% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 8.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -7.00% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 31.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Imaging Dynamics Co was 69.00% per year. The lowest was -45.30% per year. And the median was 25.50% per year.
Imaging Dynamics Co (OTCPK:IDYLF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Imaging Dynamics Co 3-Year EBITDA Growth Rate Related Terms
IDYLF vs ABT, SYK, MDT: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, Imaging Dynamics Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Imaging Dynamics Co 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Imaging Dynamics Co's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Imaging Dynamics Co's 3-Year EBITDA Growth Rate falls into.
Imaging Dynamics Co 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 8.30% mean?
Imaging Dynamics Co (IDYLF) has a 3-Year EBITDA Growth Rate of 8.30% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Imaging Dynamics Co and its competitors. This is 67% below median its historical median of 25.50. According to the industry distribution chart, Imaging Dynamics Co ranks #342 out of 688 companies in the Medical Devices & Instruments industry, placing it in the top 49.7%.
Is Imaging Dynamics Co's 3-Year EBITDA Growth Rate too high?
Imaging Dynamics Co's current 3-Year EBITDA Growth Rate of 8.30% is 67% below median its 10-year median of 25.50. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 7.90. Imaging Dynamics Co's value of 8.30% is 5.1% above this industry median. Based on the distribution chart, Imaging Dynamics Co ranks #342 out of 688 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Imaging Dynamics Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Imaging Dynamics Co's 3-Year EBITDA Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Imaging Dynamics Co ranks #342 out of 688 companies for 3-Year EBITDA Growth Rate. This puts Imaging Dynamics Co in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 7.90. Imaging Dynamics Co's value of 8.30% is 5.1% above this benchmark. While the company's 10-year median is 25.50 vs. the industry median of 7.90, Imaging Dynamics Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 7.90, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Imaging Dynamics Co's current 3-Year EBITDA Growth Rate of 8.30% is 5.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Imaging Dynamics Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imaging Dynamics Co's current 3-Year EBITDA Growth Rate is 8.30%, which is 67% below median its own 10-year median of 25.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Dynamics Co stock overvalued right now?
Imaging Dynamics Co (IDYLF) has a current 3-Year EBITDA Growth Rate of 8.30%. The stock's GF Value™ is $0.01, compared to a current price of $0.02 — trading 135% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 8.30%, which is 67% below median its 10-year median of 25.50 and 5.1% above the Medical Devices & Instruments industry median of 7.90. Imaging Dynamics Co's overall GF Score™ is 9/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Imaging Dynamics Co (IDYLF), the current 3-Year EBITDA Growth Rate is 8.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Imaging Dynamics Co (IDYLF) Overvalued in 2026?
Based on GuruFocus' analysis, Imaging Dynamics Co stock appears to be overvalued.
The current stock price of $0.02 is trading 135% above its estimated GF Value™ of $0.01.
Key valuation signals for IDYLF:
3-Year EBITDA Growth Rate: 8.30% (67% below median its 10-year median of 25.50)
GF Value™: $0.01 vs. price of $0.02 (135% above fair value)
Industry Position: 5.1% above the Medical Devices & Instruments median (#342 of 688)
No single metric tells the full story. See the IDYLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Imaging Dynamics Co Ltd is engaged in the sale of medical imaging devices. Its products include 1600Plus X-series, Veterinary DR System, Magellan medical image processing software, Sirius Veterinary image processing software, CCD technology, Aquarius 8600, and VetnovaXion DR series. It sells mainly through dealers, distributors, and OEM partners. The company has sales in two geographic areas within one operating segment, consisting of the Americas and other, with the majority of revenue from the Americas.
9GF Score
Get the complete analysis for IDYLF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IDYLF has been successfully added to your 
